Metabolic Interventions (Time-Restricted Eating, GLP1 Receptor Agonist, and Heart Healthy Diet) to Improve Cardiometabolic Health in Prostate Cancer Patients During Androgen Deprivation Therapy, IMPACT-ADT Trial
NCT07202247 · Recruiting
Last updated 2026-05-28This clinical trial is testing whether time-restricted eating, a GLP1 receptor agonist, or a heart-healthy diet can improve heart and metabolic health in men with prostate cancer who are undergoing androgen deprivation therapy.
What this study is testing ClinicalTrials.gov NCT07202247 ↗
Description as written by the study sponsor.
This phase II trial compares the effect of time-restricted eating (TRE) and glucagon-like peptide-1 (GLP1) receptor agonists (RA), semaglutide and tirzepatide, to an American Heart Association (AHA) heart healthy diet (HHD) intervention on heart and blood vessel health (cardiovascular system) and how the body processes food for energy (metabolic system) in prostate cancer patients undergoing androgen deprivation therapy (ADT). Prostate cancer patients who are receiving hormonal therapy (ADT) are at an increased risk of cardiovascular disease. This is thought to be due to treatment-related metabolic changes which may result in increased weight, body fat, insulin resistance and an increased risk of heart attack, stroke or other heart and blood vessel problems. TRE (also known as intermittent fasting) is an eating plan that alternates between fasting and non-fasting periods. This approach limits calorie intake to a specific window of time each day. GLP1-RAs, semaglutide and tirzepatide are in a class of medications called incretin mimetics. They work by helping the pancreas to release the right amount of insulin when blood sugar levels are high. Insulin helps move sugar from the blood into other body tissues where it is used for energy. They also slow the movement of food through the stomach and may decrease appetite and cause weight loss. The AHA HHD guidelines may be an effective method to help people learn about following a heart healthy eating plan. This may lower their risk of cardiovascular disease. Metabolic interventions, TRE and GLP1-RA, may be more effective than an AHA HHD intervention alone in improving cardiovascular and metabolic health in prostate cancer patients undergoing ADT.
Treatments tested
- Antiandrogen Therapy also known as ADT, Androgen Deprivation Therapy, Androgen Deprivation Therapy (ADT), Anti-androgen Therapy, Anti-androgen Treatment, Antiandrogen Treatment, Hormone Deprivation Therapy, Hormone-Deprivation Therapy Drug
Given ADT
- Behavioral Intervention also known as Behavior Conditioning Therapy, Behavior Modification, Behavior or Life Style Modifications, Behavior Therapy, Behavioral, Behavioral Interventions, Behavioral Modification, Behavioral Therapy, Behavioral Treatment, Behavioral Treatments Behavioral
Receive fasting reminders via Oncpatient Companion Mobile Application
- Biospecimen Collection also known as Biological Sample Collection, Biospecimen Collected, Specimen Collection Procedure
Undergo blood sample collection
- Cardiac Computerized Tomographic Angiography Procedure
Undergo a coronary computerized tomography angiography
- Computed Tomography also known as CAT, CAT Scan, Computed Axial Tomography, Computerized Axial Tomography, Computerized axial tomography (procedure), Computerized Tomography, Computerized Tomography (CT) scan, CT, CT Scan, Diagnostic CAT Scan, Diagnostic CAT Scan Service Type, tomography Procedure
Undergo CT
- Electronic Health Record Review Other
Ancillary studies
- Internet-Based Intervention Other
Complete survey and food diary collection via Oncpatient Companion Mobile Application
- Lifestyle Counseling Behavioral
Receive diet and lifestyle counseling
- Medical Device Usage and Evaluation Other
Wear an activity tracker
- Nutritional Intervention Other
Receive AHA HHD guidelines
- Nutritional Intervention Other
Receive AHA Life Essential 8 recommendations with personalized caloric intake
- Questionnaire Administration Other
Ancillary studies
- Radiation Therapy also known as Cancer Radiotherapy, Energy Type, ENERGY_TYPE, Irradiate, Irradiated, Irradiation, Radiation, Radiation Therapy, NOS, Radiotherapeutics, Radiotherapy, RT, Therapy, Radiation Radiation
Undergo RT
- Referral also known as Referred Other
Receive a referral to an endocrinologist
- Semaglutide also known as Ozempic, Rybelsus, Wegovy Drug
Given SC
- Short-Term Fasting also known as Intermittent Fasting, Short-term Intermittent Fasting Other
Participate in an overnight fast
- Tirzepatide Drug
Given SC
| Main thing measured | Changes in the 10-year risk of cardiovascular disease |
|---|---|
| Sponsor | City of Hope Medical Center |
| Conditions studied | Prostate Carcinoma, Recurrent Prostate Carcinoma |
| GLP-1 drugs | — |
Full protocol, eligibility, and contacts on ClinicalTrials.gov NCT07202247 ↗